Literature DB >> 11503168

Frequency and ethnic distribution of the common DHCR7 mutation in Smith-Lemli-Opitz syndrome.

M J Nowaczyk1, L M Nakamura, B Eng, F D Porter, J S Waye.   

Abstract

Smith-Lemli-Opitz syndrome (SLOS) is an inherited multiple malformation syndrome caused by enzymatic deficiency of 3beta-hydroxysterol-Delta(7)-reductase (DHCR7). SLOS is thought to be most common among European Caucasians, with an incidence of 1 in 20,000 to 1 in 30,000 births. To define the carrier rate and ethnic distribution of SLOS, we screened DNA samples from 2,978 unrelated individuals for the most common SLOS mutation (IVS8-1G-->C). Twenty-four heterozygotes of the IVS8-1G-->C mutation were detected in 2,978 individuals of European Caucasian and Black backgrounds. For European Caucasians, the carrier rate for SLOS may be as high as 1 in 30, suggesting an incidence of 1 in 1,700 to 1 in 13,400. This high number is supported by the recent observation of newborn and prenatal incidence of 1 in 22,000 in the Caucasian population. Ours is the first report of the IVS8-1G-->C mutation in persons of African ancestry. Published 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11503168     DOI: 10.1002/ajmg.1441

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

2.  R352Q mutation of the DHCR7 gene is common among Japanese Smith-Lemli-Opitz syndrome patients.

Authors:  Yoshiyuki Matsumoto; Ken-Ichi Morishima; Akira Honda; Shoji Watabe; Misa Yamamoto; Masayuki Hara; Masaki Hasui; Chikako Saito; Toshimitsu Takayanagi; Tsutomu Yamanaka; Nakamichi Saito; Hideaki Kudo; Nobuhiko Okamoto; Masato Tsukahara; Shinya Matsuura
Journal:  J Hum Genet       Date:  2005-07-26       Impact factor: 3.172

3.  Smith-Lemli-Opitz Mutations in Unexplained Stillbirths.

Authors:  Karen J Gibbins; Uma M Reddy; George R Saade; Robert L Goldenberg; Donald J Dudley; Corette B Parker; Vanessa Thorsten; Halit Pinar; Radek Bukowski; Carol J Hogue; Robert M Silver
Journal:  Am J Perinatol       Date:  2018-02-12       Impact factor: 1.862

4.  Growth charts for individuals with Smith-Lemli-Opitz syndrome.

Authors:  Ryan W Y Lee; John McGready; Sandra K Conley; Nicole M Yanjanin; Małgorzata J M Nowaczyk; Forbes D Porter
Journal:  Am J Med Genet A       Date:  2012-05-21       Impact factor: 2.802

5.  Increasing cholesterol synthesis in 7-dehydrosterol reductase (DHCR7) deficient mouse models through gene transfer.

Authors:  Xavier Matabosch; Lee Ying; Montserrat Serra; Christopher A Wassif; Forbes D Porter; Cedric Shackleton; Gordon Watson
Journal:  J Steroid Biochem Mol Biol       Date:  2010-08-26       Impact factor: 4.292

6.  Temporal changes in the brain lipidome during neurodevelopment of Smith-Lemli-Opitz syndrome mice.

Authors:  Amy Li; Kelly M Hines; Dylan H Ross; James W MacDonald; Libin Xu
Journal:  Analyst       Date:  2022-04-11       Impact factor: 5.227

7.  Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome).

Authors:  Josep Marcos; Cedric H L Shackleton; Madhavee M Buddhikot; Forbes D Porter; Gordon L Watson
Journal:  Steroids       Date:  2007-07-13       Impact factor: 2.668

8.  Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

Authors:  Katie T Jenkins; Louise S Merkens; Matthew R Tubb; Leslie Myatt; W Sean Davidson; Robert D Steiner; Laura A Woollett
Journal:  Mol Genet Metab       Date:  2008-03-17       Impact factor: 4.797

Review 9.  Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review.

Authors:  M R Boland; N P Tatonetti
Journal:  Pharmacogenomics J       Date:  2016-07-12       Impact factor: 3.550

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.